PKTX (ProtoKinetix) FCF Margin %: 0.00% (As of Sep. 2025)


What is ProtoKinetix FCF Margin %?

ProtoKinetix PKTX FCF Margin % is 0.00% as of Sep. 2025. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, ProtoKinetix ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ProtoKinetix's Free Cash Flow for the three months ended in Sep. 2025 was $-0.01 Mil. ProtoKinetix's Revenue for the three months ended in Sep. 2025 was $0.00 Mil. Therefore, ProtoKinetix's FCF Margin % for the quarter that ended in Sep. 2025 was 0.00%.

As of today, ProtoKinetix's current FCF Yield % is -10.95%.

The historical rank and industry rank for ProtoKinetix's FCF Margin % or its related term are showing as below:


PKTX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

ProtoKinetix FCF Margin % Related Terms

ProtoKinetix FCF Margin % Historical Data

* Premium members only.

The historical data trend for ProtoKinetix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProtoKinetix FCF Margin % Chart

ProtoKinetix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ProtoKinetix Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PKTX vs BBLG, JAGX, VBIO: FCF Margin % Comparison

For the Biotechnology subindustry, ProtoKinetix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProtoKinetix FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProtoKinetix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ProtoKinetix's FCF Margin % falls into.


ProtoKinetix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ProtoKinetix's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.281/0
= %

ProtoKinetix's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.01/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
ProtoKinetix (PKTX) has a FCF Margin % of 0.00% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProtoKinetix and its competitors. According to the industry distribution chart, ProtoKinetix ranks #999999 out of 960 companies in the Biotechnology industry.
Is ProtoKinetix's FCF Margin % too high?
ProtoKinetix's current FCF Margin % is 0.00%. Based on the distribution chart, ProtoKinetix ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does ProtoKinetix's FCF Margin % compare to BBLG and JAGX?
According to the Biotechnology industry distribution chart, ProtoKinetix ranks #999999 out of 960 companies for FCF Margin %. This places ProtoKinetix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProtoKinetix and its competitors. ProtoKinetix's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProtoKinetix stock overvalued right now?
ProtoKinetix (PKTX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ProtoKinetix (PKTX), the current FCF Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProtoKinetix Business Description

Address 109 W Main Street, Dalton, OH, USA, 44618
ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.